Anterior Suprascapular and Axillary vs. Interscalene Block for Analgesia and Diaphragmatic Function in Shoulder Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAnkara Etlik City Hospital

About this trial

Shoulder surgeries are among the most frequently performed orthopedic interventions and are often associated with moderate to severe postoperative pain. In these procedures, effective pain management is crucial for early rehabilitation and patient comfort.

Peripheral nerve blockade is widely used for postoperative analgesia in shoulder surgery. While the interscalene brachial plexus block is considered the gold standard for pain control, it is frequently associated with unintended phrenic nerve blockade, leading to hemidiaphragmatic paresis. To minimize respiratory complications while maintaining effective analgesia, alternative diaphragm-sparing regional anesthesia techniques, such as the combination of suprascapular and axillary nerve blocks, have been introduced.

The aim of this study is to compare the analgesic efficacy and respiratory functions preservation of the ultrasound-guided anterior approach suprascapular combined with axillary nerve block versus interscalene block in patients undergoing shoulder surgery

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged between 18 and 65 years

American Society of Anesthesiologists (ASA) physical status I, II, or III

Patients scheduled to undergo elective arthroscopic shoulder surgery

BMI between 18 and 30 kg/m2

Disqualifiers

Known allergy or hypersensitivity to local anesthetics

Presence of localized infection at the planned injection site

Severe coagulopathy or active use of anticoagulant medications

Contralateral phrenic nerve palsy or a diagnosis of severe chronic obstructive pulmonary disease (COPD)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Interscalene Block

    Procedure/Surgery

    Interscalene block will be performed on the patients using 10 mL of 0.5% bupivacaine under ultrasound guidance.

  • Combination of Axillary and Anterior Suprascapular Blocks

    Procedure/Surgery

    Combined anterior suprascapular(5 ml) and axillary nerve blocks(5 ml) will be performed on the patients using a total of 10 mL of 0.5% bupivacaine under ultrasound guidance.

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Interscalene BlockActive comparator 1 intervention
Group B: Combination of Axillary and Anterior Suprascapular BlocksActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative Pain Intensity at Rest

Pain will be assessed using a visual analog scale from 0 mm (no pain) to 100 mm (worst pain) at rest. Pain assessment at rest will be made at 4 hours after surgery.

Time frame
4 hours after surgery.

Secondary outcomes

1

Postoperative Pain Intensity at Rest

Pain will be assessed using a visual analog scale from 0 mm (no pain) to 100 mm (worst pain) at rest. Pain assessment at rest will be made at 1, 8, 12, and 24 hours after surgery.

Time frame
Up to 24 hours
2

Postoperative Pain Intensity at Movement

Pain will be assessed using a visual analog scale from 0 mm (no pain) to 100 mm (worst pain) at movement. Pain assessment at rest will be made at 1, 4, 8, 12, and 24 hours after surgery.

Time frame
Up to 24 hours
3

Total Postoperative Opioid Consumption

The total amount of opioid consumed by the patient will be recorded.

Time frame
Up to 24 hours
4

Area Under Curve

Cumulative 24-hour pain burden calculated by the trapezoidal rule

Time frame
At the 24th hour

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.